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Introduction
Emergence and global spread of vancomycin resistant
Enterococcus spp. (VRE)1 is of great concern due to limited
therapeutic options.2 Infections with VRE have high mortality
rate, prolonged hospital stay and. increased costs.3-5
Epidemiology of VRE is complex. This is due to clonal spread
of strains because of breach in infection control measures as
well as evolution of new strains due to antibiotic pressure.6,7
Moreover resistant genes in Enterococcus spp. mainly vanA
and vanB genes are plasmid mediated and have the potential
to disseminate to more virulent pathogens such as
Staphylococcus aureus (S. aureus).8 Thus large scale
emergence of vancomycin resistant S. aureus may be the next
stage in the global crisis of antimicrobial resistance. Major
strategies to control nosocomial transmission of VRE include
"passive surveillance", with isolation of all patients with
known previous or current VRE colonization, and "active
surveillance" which uses admission cultures, with subsequent
isolation of patients who are found to be colonized with VRE.9
Increase in the isolation rates of VRE has been
reported from hospitals globally including various countries
in Asia.10,11 VRE was first reported from Pakistan in year
2002 from Aga Khan University hospital (AKUH).12 The
results of that study revealed monoclonal spread of vanA
gene containing strain in adult and neonatal intensive care
unit settings. Cross transmission was identified as probable
mode of spread. Analysis of AKUH clinical laboratory data
over a period of 6 years (from 2002 to date) has revealed
increased VRE isolation in clinical samples from other
centers in the city (unpublished data). This increase in
frequency of VRE is alarming. 
In order to curtail this emerging burden of VRE, it is
imperative to conduct studies that will give better insight of
molecular epidemiology of local VRE strains. Therefore in
this study we determined the molecular epidemiology of
nosocomoial strains of VRE from 6 tertiary care centers of
Karachi. The results of this study will help to identify the
genotype and clonality of the nosocomial strains prevalent in
various hospitals of Karachi, Pakistan.
Material and Methods
This cross sectional study was conducted in the
clinical and research laboratory of AKUH, Karachi, Pakistan
from October 2007 to September 2008. We studied 86 VRE
isolates (65 from AKUH and 21 from five other tertiary care
hospitals of Karachi) from clinical and surveillance samples.
Convenient sampling technique was utilized to collect the
isolates. Sources were pus, tissue, urine, blood and rectal
swab. Enterococcus spp. was identified using standard
methodology.13 Antimicrobial testing were performed by
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Abstract
Objective: To perform molecular typing of vancomycin resistant Enterococcus spp. (VRE) strains endemic in
various hospitals of Karachi, to characterize the mechanism of glycopeptide resistance and assess the genetic
relatedness, for understanding its transmission locally.
Method: This was a cross sectional study conducted in the clinical and research laboratory of Aga Khan
University Hospital (AKUH), Karachi, Pakistan from October 2007 to September 2008. Non-duplicate 86 (65
AKUH and 21 non-AKUH) VRE strains were included. Molecular typing of nosocomial isolates of VRE was
carried out by using Pulsed field gel electrophoresis (PFGE) and identification of vanA and vanB genes were
performed by conventional Polymerase Chain Reaction (PCR).
Results: Analysis of PFGE data by Tenover scheme showed single major pulsotype A with its subtypes A1, A2
and A3 present among different tertiary hospitals in Karachi. The dice coefficient of similarity among AKUH, non-
AKUH and total 86 (AKUH and non-AKUH) had a value of 90%, 88% and 89% reflecting their clonal relatedness.
In all 60/65 (92%) and 19/21 (90%) AKUH and non-AKUH isolates had vanA gene respectively. None had vanB
gene.
Conclusion: Molecular typing suggested that VRE isolates had same clonal origin indicating nosocomial
transmission. Institution of strict infection control measures with active surveillance should be taken to avoid its
further spread (JPMA 60:805; 2010).
Kirby-Bauer disk diffusion method according to Clinical
Laboratories Standards Institute (CLSI).14 Vancomycin
(30µg) disc was used for screening, followed by agar plate
containing 6mg/L vancomycin to confirm vancomycin
resistance. Ampicillin (10µg), amoxicillin/clavulanic acid
(20/10µg), chloramphenicol (30µg), gentamicin (120µg),
erythromycin (15µg), tetracycline (30µg), teicoplanin (30µg)
and linezolid (30µg) were used to detect susceptibility. VRE
were stored at -80°C in glycerol phosphate buffer.
DNA Extraction:
DNA was extracted using the Wizard genomic DNA
purification kit (Promega, USA) according to the
manufacturer,s instruction with lysozyme (10mg/ml) and
mutanolysin (50U). The DNA concenteration was determined
by Nanodrop (ND-1000; NanoDrop Technologies Inc., USA).
Polymerase Chain Reaction (PCR):
The vanA and vanB genes were detected by
performing conventional PCR. The primers used to amplify
vanA and vanB genes were VanABF;
GTAGGCTGCGATATTCAAAGC, Van AR,
CGATTCAATTGCGTAGTCCAA and VanBR,
GCCGACAATCAAATCATCCTC. PCR amplifications
were performed in a total reaction mixture of 25µl with PCR
master mix (Promega, USA) containing 1µl of 30ng template
DNA and 0.4µM of each primer. The reactions were
performed on a Perkin-Elmer Gene Amp® 9700 thermal
cycler for 30 cycles with the following cycling parameters:
initial denaturation at 94°C for 3min, denaturation at 94% for
30s, annealing at 55°C for 30s, extension at 72°C for 1min,
and final extension at 72°C for 5 min. E. faecalis ATCC
51559 and E. faecalis ATCC 51299 were positive control for
vanA and vanB respectively. E. faecium ATCC 19433 was
included in each experiment as negative control in vanA and
vanB detection respectively along with a reagent control
blank. PCR products were then analyzed by loading 10µl of
the amplicon on a 1% agarose gel prepared in 1X Tris Borate
EDTA (TBE) buffer run at 100V. The gels were stained with
ethidium bromide and photographed using Quantity One
Software gel documentation system (Bio-Rad, USA).
Pulsed Field Gel Electerophoresis (PFGE):
VRE isolates were subcultured on blood agar for 4
hours at 37°C and isolated colonies were grown overnight in
brain heart infusion broth for 16-18 hours. The cells were
pelleted by centrifuging at 12,000xg twice for 5 minutes and
washed with 2ml Pett IV (PIV) solution (10Mm Tris-Cl [pH
7.4], 1M NaCl) and then pellets resuspended in 2ml PIV
solution. 500µl of resuspended solutions was mixed with
125U Mutanolysin and equal amount of 1.6% low melting
point agarose (Sigma-Aldrich, USA) and cast into plug
molds. The plugs were allowed to solidify for 15 minutes at
room temperature and placed in lysis solution (6mM Tris-Cl
[pH 7.4], 1M NaCl, 0.1M EDTA, 0.5% Brij58, 0.2%
deoxylate, 0.5% Sodium lauroysarcosine, lysozyme
[1mg/ml], RNase [0.028mg/ml]) to incubate overnight at
370C. The lysis solution was replaced by 10ml proteolysis
solution (0.4 M EDTA, 1% Sodium lauroysarcosine,
Proteinase K [1mg/ml; Promega, USA]) and the tubes were
incubated overnight at 50°C. The plugs were then washed
thrice with 15 ml 1X TE buffer (10 mM Tris-Cl, 1mM EDTA
[pH 8.0]) for 45 min and stored at 40°C. A thin slice (2 mm)
of the plug was equilibrated with 100µl restriction buffer (1X
Buffer J, 0.1 mg/ml BSA, Nuclease free water) and the tubes
were placed on ice for 30 minutes, which was replaced by
restriction enzyme buffer to digest the DNA with 20U Sma-1
(Promega, USA). The tubes were again kept on ice for 15
minutes and the reaction mixture was incubated overnight at
25°C. Plugs were loaded into the wells of 1.2% agarose (Bio-
Rad, USA) gel and run in 0.5X TBE using a contour-clamped
homogenous electric-field electrophoresis (Bio-Rad, USA).
The following parameters were set for electrophoresis: 200V
(6v/CM), temperature: 14°C, initial switch time: 5s; final
switch time: 35s, inclined angle:1200 and a total run time of
24 hrs. The gel was stained with ethidium bromide for 30
minutes and visualized under a UV light.
PFGE Fingerprint Analysis:
The visual analysis of PFGE fingerprints was
performed according to the criteria of Tenover et al.15 Isolates
with PFGE profiles differed by three or fewer bands were
grouped in same PFGE type and those differed by four to six
bands were assigned to subtypes of the same type. Isolates
with difference of more than six bands were considered
unrelated and assigned to different group. Major PFGE
patterns were named using capital letters (e.g. A,B,C) and
similar PFGE patterns were classified as subtypes of a major
pattern using an Arabic number following the capital letters.
(e.g. A1, A2). A computer assisted dendogram of fragment
patterns was constructed by using BioNumerics software
(version 4.5; Applied Maths). Clustering was obtained by the
unweighted pair group method using average linkages
(UPGMA) with the Dice similarity coefficient.
Data Management and statistical analysis: 
The data was coded and entered into SPSS 16.0
software for statistical analysis. Frequencies of VRE
genotype A and B were calculated and the percentage
similarity of VRE pulsotypes from within AKUH and other
Karachi hospitals was determined.
Result
A total of 86 strains were used in this study, of which
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65 were from AKUH and 21 from other 5 tertiary care
hospitals of Karachi. 
PFGE Profiles:
Analysis of PFGE data (Figure-1) by Tenover scheme
showed 1 major pulsotype A with 3 subtypes A1, A2 and A3
among 65 AKUH isolates. The major pulsotype A was 62%
(n=40) and 3 subtypes, were A1 25% (n=16), A2 9% (n=6)
and A3 4% (n=3) respectively. Among 21 non-AKUH strains
same major pulsotype A with its subtypes A1, A2 and A3
were present. Pulsotype A was 38% (n=8) and subtypes, A1,
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Table: Prevalent pulsotypes and genotypes of
VRE during study period.
Hospital (number Pulsotypes Number (%) Dice co-efficient
of isolates) of similarity
AKUH (65) A 40 (62) 90%
A1 16 (25)
A2 6 (9)
A3 3 (4)
Non-AKUH (21) A 8 (38) 88%
A1 4 (19)
A2 5 (24)
A3 4 (19)
AKUH-Non-AKUH (86) A 48 (56) 89%
A1 20 (23)
A2 11 (13)
A3 7 (8)
Figure-1: Pulsed field gel electrophoresis profile of VRE isolates.
Lane 1, DNA  PFGE ladder; lane 2, A; lane 3, A; lane 4, A3;
lane 5, A1; lane 6, A, lane 7 A, lane 8, A1;lane 9, A2.
Figure-3: Identification of vanA by PCR. Lane 1, 100bp ladder; lane 2, vanA
positive control; lane 3, AKUH test strain; lane 4, non AKUH test strain; lane 5,
vanA negative control; lane 6, blank.
Figure-2: Dendrogram of 86 VRE isolates of AKUH and 5 district hospital of Karachi
typed by PFGE demonstrating clonal relatedness with 88% similarity in banding
pattern by dice coefficient, Tenovir pulsotypes A and its subtypes A1, A2 and A3.
A2 and A3 were 19% (n=4), 24% (n-5) and 19% (n=4)
respectively Among total 86 isolates (AKUH and non-
AKUH), the major pulsotype A was 56% (n=48) and 3
subtypes, were A1 23% (n=20), A2 13% (n=11) and A3 8%
(n=7) respectively (Table).   
The dice coefficient of similarity among AKUH, non-
AKUH and total 86 had a value of 90%, 88% and 89%
reflecting their clonal relatedness (Figure-2).  
Genotype Profile:
60/65 (92%) isolates from AKUH and 19/21 (90%)
isolates from non-AKUH had vanA gene (Figure-3). None of
isolates showed PCR signals for vanB gene. 
Antimicrobial susceptibility Profile:
Analysis of susceptibility profile revealed that all
isolates from AKUH and non-AKUH were sensitive to
chloremphenicol and linezolid and resistant to ampicillin,
amoxicillin/clavulanic acid, erythromycin, teicoplanin,
tetracycline and gentamicin, suggesting clonal relatedness.
Discussion
Analysis of our results indicate vanA gene as common
determinant for glycopeptide resistance in Enterococcus spp
and clonal dissemination of VRE in different hospitals in our
population. 
As epidemiology of VRE is composite, involving
clonal spread, transfer of genetic elements and the
introduction of new strains. Increase in incidence has been
associated with different factors such as antibiotic selective
pressure (uncontrolled use of vancomycin), lack of
surveillance and hospital infection control policies.
Predominance of one clone suggests frequent transfer
of patients from one ward to another ward as well as from one
hospital to another. These findings highlight lack of infection
control policies and surveillance of VRE colonized/infected
patients during inter/ intra- hospital transfer in the city.  
Clonal dissemination of vanA gene encoded VRE
have been reported from other parts of world. A study from
UK reported cross transmission resulting in spread of VRE in
their hospital, with predominance of single pulsotype with
92% containing vanA gene.16 Similarly molecular typing of
VRE strains from Argentina have shown predominance of
one epidemic clone carrying vanA element in different
hospitals, reflecting increase in incidence of clonal spread of
VRE..17 A study from India showed presence of only vanA
gene in their isolates.18 Similarly molecular typing of VRE
strains from Brazil showed 7 pulsotypes, with predominance
of one type in different hospitals, reflecting spread of single
strain in various hospitals. But they also discussed heavy
antibiotic selective pressure due to frequent use of
vancomycin was the reason of presence of different
pulsotypes.19 In contrast to our findings Bell et al from
Australia showed considerable diversity in VRE phenotypes
and genotypes and related this finding with higher of usage of
vancomycin in both human and animals.20
Improper surveillance and infection control measures
remain the major factor responsible for dissemination of
VRE. To control its spread, the society for Healthcare
Epidemiology of America (SHEA) made a guideline
implicating the search and destroy policy. According to that
active surveillance cultures are essential to identify the
reservoir and make control possible using the CDCs
recommended contact precautions.21 Calfee et al from
Virginia was able to reduce their VRE incidence rate from
2.07 to 1.25% and maintained it after application of active
surveillance and contact isolation.22 Price et al from Chicago
found lower VRE bacteraemia and a more polyclonal
population resulted from active surveillance and then contact
isolation of high risk population.23
In Pakistan, uncontrolled use of vancomycin sets the
stage for selection of VRE while lack of active surveillance to
detect VRE has lead to its clonal spread to major district health
hospitals of Karachi. This finding is a warning for health
agencies in Pakistan as majority of strains have vanA
genotype which has the potential to transmit resistant
determinant to more virulent organism like S. aureus, mostly
endemic in our tertiary care hospitals. Prompt attention for the
detection of new cases of VRE colonization and employment
of infection control policies are strongly emphasized.
Although advance molecular techniques are important
in identifying breakdown in infection control measures,
however in resource limited country like Pakistan, role of a
simple measure like careful interpretation of antibiogram
should not be underestimated and can be a useful screening
tool for early recognition of clonal spread of resistant isolates
in our setting.
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